p45 NF‐E2 regulates expression of thromboxane synthase in megakaryocytes

Transcription factor p45 NF‐E2 is highly expressed in the erythroid and megakaryocytic lineages. Although p45 recognizes regulatory regions of several erythroid genes, mice deficient for this protein display only mild dyserythropoiesis but have abnormal megakaryocytes and lack circulating platelets. A number of megakaryocytic marker genes have been extensively studied, but none of them is regulated by NF‐E2. To find target genes for p45 NF‐E2 in megakaryopoiesis, we used an in vivo immunoselection assay: genomic fragments bound to p45 NF‐E2 in the chromatin of a megakaryocytic cell line were immunoprecipitated with an anti‐p45 antiserum and cloned. One of these fragments belongs to the second intron of the thromboxane synthase gene (TXS). We demonstrate that the TXS gene, which is mainly expressed in megakaryocytes, is indeed directly regulated by p45 NF‐E2. First, its promoter contains a functional NF‐E2 binding site; second, the intronic NF‐E2 binding site is located within a chromatin‐dependent enhancer element; third, p45‐null murine megakaryocytes do not express detectable TXS mRNA, although TXS expression can be detected in other cells. These data, and the structure of the TXS promoter and enhancer, suggest that TXS belongs to a distinct subgroup of genes involved in platelet formation and function.

[1]  N. Andrews,et al.  Human MafG is a functional partner for p45 NF-E2 in activating globin gene expression. , 1997, Blood.

[2]  K. Itoh,et al.  Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site , 1996, Molecular and cellular biology.

[3]  B. Emerson,et al.  NF-E2 disrupts chromatin structure at human beta-globin locus control region hypersensitive site 2 in vitro , 1996, Molecular and cellular biology.

[4]  R. Eisenman,et al.  Myc‐Max heterodimers activate a DEAD box gene and interact with multiple E box‐related sites in vivo. , 1996, The EMBO journal.

[5]  M. Shago,et al.  Isolation of a novel retinoic acid-responsive gene by selection of genomic fragments derived from CpG-island-enriched DNA , 1996, Molecular and cellular biology.

[6]  P. Romeo,et al.  Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. , 1996, Blood.

[7]  G. Dressler,et al.  Identification of Novel Pax-2 Binding Sites by Chromatin Precipitation (*) , 1996, The Journal of Biological Chemistry.

[8]  T. Wagner,et al.  Long‐Term Expression of Human Growth Hormone (hGH) in Mice Containing Allogeneic Yolk Sac Cell Derived Neovascular Implants Expressing hGH , 1996, Stem cells.

[9]  M. Hartl,et al.  Specific activation in jun-transformed avian fibroblasts of a gene (bkj) related to the avian beta-keratin gene family. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Eisenman,et al.  Novel location and function of a thyroid hormone response element. , 1995, The EMBO journal.

[11]  J. Ware,et al.  Identification of Essential GATA and Ets Binding Motifs within the Promoter of the Platelet Glycoprotein Ibα Gene (*) , 1995, The Journal of Biological Chemistry.

[12]  S. Heinemann,et al.  Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  K. Itoh,et al.  Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins , 1995, Molecular and cellular biology.

[14]  S. Orkin,et al.  Dependence of globin gene expression in mouse erythroleukemia cells on the NF-E2 heterodimer , 1995, Molecular and cellular biology.

[15]  E. Flemington,et al.  Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1 , 1995, Journal of virology.

[16]  S. Orkin,et al.  Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoeitin/MGDF in megakaryocyte development , 1995, Cell.

[17]  R. Mann,et al.  Identification of homeotic target genes in Drosophila melanogaster including nervy, a proto-oncogene homologue. , 1995, Genetics.

[18]  K. Kataoka,et al.  Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor , 1995, Molecular and cellular biology.

[19]  K. Itoh,et al.  Activity and Expression of Murine Small Maf Family Protein MafK (*) , 1995, The Journal of Biological Chemistry.

[20]  T. Enver,et al.  Targeting gene expression to haemopoietic stem cells: a chromatin‐dependent upstream element mediates cell type‐specific expression of the stem cell antigen CD34. , 1995, The EMBO journal.

[21]  D. Brenner,et al.  A single promoter directs both housekeeping and erythroid preferential expression of the human ferrochelatase gene. , 1994, The Journal of biological chemistry.

[22]  K. Ravid,et al.  Characterization of regulatory elements in the 5'-flanking region of the rat GPIIb gene by studies in a primary rat marrow culture system. , 1994, Blood.

[23]  R. Eisenman,et al.  Isolation of a thyroid hormone-responsive gene by immunoprecipitation of thyroid hormone receptor-DNA complexes , 1994, Molecular and cellular biology.

[24]  Y. Kan,et al.  Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Beach,et al.  Cyclin G is a transcriptional target of the p53 tumor suppressor protein. , 1994, The EMBO journal.

[26]  S. Bandoh,et al.  Characterization of the human gene (TBXAS1) encoding thromboxane synthase. , 1994, European journal of biochemistry.

[27]  S. Rowan,et al.  Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: evidence that NF-E2 is essential for globin expression. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  T. Townes,et al.  Cloning and functional characterization of LCR-F1: a bZIP transcription factor that activates erythroid-specific, human globin gene expression. , 1994, Nucleic acids research.

[29]  G. Keller,et al.  Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. , 1994, Genes & development.

[30]  R. Behringer,et al.  Multiple elements in human beta-globin locus control region 5' HS 2 are involved in enhancer activity and position-independent, transgene expression. , 1994, Nucleic acids research.

[31]  P. Romeo,et al.  Structure and transcription of the human c-mpl gene (MPL). , 1994, Genomics.

[32]  Ken Itoh,et al.  Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins , 1994, Nature.

[33]  S. Orkin,et al.  The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Y. Kan,et al.  Isolation of cDNA encoding the human NF-E2 protein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Y. Kan,et al.  Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Y. Ouchi,et al.  Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Pan,et al.  Characterization of the promoter for the human P-selectin gene. , 1993, The Journal of biological chemistry.

[38]  J. Cazenave,et al.  Cloning and characterization of the gene encoding the human platelet glycoprotein V. A member of the leucine-rich glycoprotein family cleaved during thrombin-induced platelet activation. , 1993, The Journal of biological chemistry.

[39]  H. Kondoh,et al.  A mouse homologue of the Drosophila tumour-suppressor gene l(2)gl controlled by Hox-C8 in vivo , 1993, Nature.

[40]  S. Orkin,et al.  DNA-binding specificity of GATA family transcription factors , 1993, Molecular and cellular biology.

[41]  Paul Tempst,et al.  Erythroid transcription factor NF-E2 is a haematopoietic-specific basic–leucine zipper protein , 1993, Nature.

[42]  F. Grosveld,et al.  Transcriptional regulation of multigene loci: multilevel control. , 1993, Trends in genetics : TIG.

[43]  M. Hickey,et al.  Characterization of the gene encoding human platelet glycoprotein IX. , 1993, The Journal of biological chemistry.

[44]  P. Romeo,et al.  GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression , 1993, Molecular and cellular biology.

[45]  D. Charmot,et al.  Homeotic control in Drosophila; the scabrous gene is an in vivo target of Ultrabithorax proteins. , 1992, The EMBO journal.

[46]  P. Herrlich,et al.  Interference between pathway‐specific transcription factors: glucocorticoids antagonize phorbol ester‐induced AP‐1 activity without altering AP‐1 site occupation in vivo. , 1992, The EMBO journal.

[47]  G. Uzan,et al.  Characterization of a specific erythromegakaryocytic enhancer within the glycoprotein IIb promoter. , 1992, The Journal of biological chemistry.

[48]  D. Strutt,et al.  Targets of homeotic gene regulation in Drosophila , 1992, Journal of Cell Science.

[49]  K. Ravid,et al.  Transcriptional regulation of the rat platelet factor 4 gene: interaction between an enhancer/silencer domain and the GATA site , 1991, Molecular and cellular biology.

[50]  F. Grosveld,et al.  The 5′HS2 of the globin locus control region enhances transcription through the interaction of a multimeric complex binding at two functionally distinct NF‐E2 binding sites. , 1991, The EMBO journal.

[51]  Robert A. H. White,et al.  Targets of homeotic gene control in Drosophila , 1990, Nature.

[52]  L. Deaven,et al.  Human platelet glycoprotein IX , 1990, FEBS letters.

[53]  A. Nienhuis,et al.  Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein. , 1990, Nucleic acids research.

[54]  F. Grosveld,et al.  Detailed analysis of the site 3 region of the human beta‐globin dominant control region. , 1990, The EMBO journal.

[55]  W. Vainchenker,et al.  Megakaryocytic and erythrocytic lineages share specific transcription factors , 1990, Nature.

[56]  K. Kinzler,et al.  The GLI gene encodes a nuclear protein which binds specific sequences in the human genome , 1990, Molecular and cellular biology.

[57]  P. Romeo,et al.  Cis- and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[58]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[59]  F. Grosveld,et al.  Two tissue-specific factors bind the erythroid promoter of the human porphobilinogen deaminase gene. , 1989, Nucleic acids research.

[60]  F. Grosveld,et al.  The human beta‐globin promoter; nuclear protein factors and erythroid specific induction of transcription. , 1988, The EMBO journal.

[61]  B. Luckow,et al.  CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements , 1987, Nucleic Acids Res..

[62]  R. Eisman,et al.  Structure of the platelet membrane glycoprotein IIb. Homology to the alpha subunits of the vitronectin and fibronectin membrane receptors. , 1987, The Journal of biological chemistry.

[63]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[64]  D. Mikhailidis,et al.  Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. , 1986, American journal of clinical pathology.

[65]  H. Sinzinger,et al.  [Deficiencies of the prostaglandin system: III. A partial thromboxane synthetase defect]. , 1985, Wiener klinische Wochenschrift.

[66]  W. C. Still,et al.  Synthesis and structure of the platelet aggregation factor thromboxane A2 , 1985, Nature.

[67]  H. Holmsen,et al.  Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets. , 1985, American journal of clinical pathology.

[68]  E. Rossi,et al.  Hereditary Bleeding Disorder due to a Primary Defect in Platelet Release Reaction , 1981, British journal of haematology.

[69]  P. Imbach,et al.  SEVERE BLEEDING ASSOCIATED WITH DEFECTIVE THROMBOXANE SYNTHETASE , 1980, The Lancet.

[70]  H. Weiss,et al.  POSSIBLE CONGENITAL DEFECT IN PLATELET THROMBOXANE SYNTHETASE , 1977, The Lancet.

[71]  M. Hamberg,et al.  Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[72]  S. Deveaux,et al.  Transcriptional Regulation in Megakaryocytes: The Thrombopoietin Receptor Gene as a Model , 1996, Stem cells.

[73]  R. Shivdasani The Role of Transcription Factor NF‐E2 in Megakaryocyte Maturation and Platelet Production , 1996, Stem cells.

[74]  M. Fussenegger,et al.  Cloning and characterization of the , 1996 .

[75]  Y. ChanJ,et al.  酵母での遺伝的選択によるNF-E2関連転写因子、Nrf1のクローニング , 1993 .

[76]  Valérie Lemarchandel Controle de l'expression des genes au cours de la differenciation megacaryocytaire. Comparaison avec la differenciation erythrocytaire , 1993 .

[77]  L. Marnett,et al.  Prostaglandin and thromboxane biosynthesis. , 1991, Pharmacology & therapeutics.